mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.28 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.03 |